UL Solutions Total Cost of Revenue decreased by 5.0% to $377.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.3%, from $365.00M to $377.00M. Over 3 years (FY 2022 to FY 2025), Total Cost of Revenue shows an upward trend with a 5.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $328.25M | $328.25M | $328.25M | $328.25M | $335.00M | $352.00M | $344.00M | $363.00M | $351.00M | $364.00M | $373.00M | $390.00M | $365.00M | $393.00M | $389.00M | $397.00M | $377.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +2.1% | +5.1% | -2.3% | +5.5% | -3.3% | +3.7% | +2.5% | +4.6% | -6.4% | +7.7% | -1.0% | +2.1% | -5.0% |
| YoY Change | — | — | — | — | +2.1% | +7.2% | +4.8% | +10.6% | +4.8% | +3.4% | +8.4% | +7.4% | +4.0% | +8.0% | +4.3% | +1.8% | +3.3% |